{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T07:39:14Z","timestamp":1769153954259,"version":"3.49.0"},"reference-count":96,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,1]]},"DOI":"10.2146\/ajhp170317","type":"journal-article","created":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T10:30:22Z","timestamp":1527244222000},"page":"755-766","source":"Crossref","is-referenced-by-count":10,"title":["Pharmacotherapy considerations for long-term management of patients with left ventricular assist devices"],"prefix":"10.1093","volume":"75","author":[{"given":"Jessica D.","family":"Nicholson","sequence":"first","affiliation":[{"name":"Indiana University Health, Indianapolis, IN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaman","family":"Kaakeh","sequence":"additional","affiliation":[{"name":"Purdue University College of Pharmacy, West Lafayette, IN"},{"name":"Indiana University School of Medicine, West Lafayette, IN"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041105263149200_b1-0750755","first-page":"e38","article-title":"Heart disease and stroke statistics\u20142016 update: a report from the American Heart Association","volume":"133","author":"Mozzafarian","year":"2016","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041105263149200_b2-0750755","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.healun.2015.10.003","article-title":"Seventh INTERMACS annual report: 15,000 patients and counting","volume":"34","author":"Kirklin","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"key\n\t\t\t\t2019041105263149200_b3-0750755","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13054-016-1328-z","article-title":"Mechanical circulatory assist devices: a primer for critical care and emergency physicians","volume":"20","author":"Sen","year":"2016","journal-title":"Crit Care"},{"key":"key\n\t\t\t\t2019041105263149200_b4-0750755","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11239-014-1162-6","article-title":"Management of anticoagulation and anti-platelet therapy in patients with left ventricular assist devices","volume":"39","author":"Baumann Kreuziger","year":"2015","journal-title":"J Thromb Thrombolysis"},{"key":"key\n\t\t\t\t2019041105263149200_b5-0750755","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.healun.2012.09.013","article-title":"The 2013 International Society for Heart and Lung Transplantation guidelines for mechanical circulatory support: executive summary","volume":"32","author":"Feldman","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"key\n\t\t\t\t2019041105263149200_b6-0750755","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/ejcts\/ezr312","article-title":"Low stroke rate and few thrombo-embolic events after HeartMate II implantation under mild anticoagulation","volume":"42","author":"Menon","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"key\n\t\t\t\t2019041105263149200_b7-0750755","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/icvts\/ivs297","article-title":"What is the optimal anticoagulation in patients with a left ventricular assist device?","volume":"15","author":"Rossi","year":"2012","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"key\n\t\t\t\t2019041105263149200_b8-0750755","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13019-015-0333-7","article-title":"Thromboembolic stroke in patients with a HeartMate-II left ventricular assist device\u2014the role of anticoagulation","volume":"10","author":"Van den Bergh","year":"2015","journal-title":"J Cardiothorac Surg"},{"key":"key\n\t\t\t\t2019041105263149200_b9-0750755","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.healun.2013.11.001","article-title":"Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device","volume":"33","author":"Kirklin","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"key\n\t\t\t\t2019041105263149200_b10-0750755","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1313385","article-title":"Unexpected abrupt increase in left ventricular assist device thrombosis","volume":"370","author":"Starling","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041105263149200_b11-0750755","doi-asserted-by":"crossref","first-page":"e002680","DOI":"10.1161\/CIRCHEARTFAILURE.115.002680","article-title":"Relationship between anticoagulation intensity and thrombotic or bleeding outcomes among outpatients with continuous-flow left ventricular assist devices","volume":"9","author":"Nassif","year":"2016","journal-title":"Circ Heart Fail"},{"key":"key\n\t\t\t\t2019041105263149200_b12-0750755","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jacc.2013.08.1656","article-title":"Preoperative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients","volume":"63","author":"Boyle","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041105263149200_b13-0750755","first-page":"20","article-title":"Dabigatran etexilate as second-line therapy in patients with a left ventricular assist device","volume":"56","author":"Terrovitis","year":"2015","journal-title":"Hellenic J Cardiol"},{"key":"key\n\t\t\t\t2019041105263149200_b14-0750755","doi-asserted-by":"crossref","first-page":"e003709","DOI":"10.1161\/CIRCHEARTFAILURE.116.003709","article-title":"Increased thromboembolic events with dabigatran compared with vitamin k antagonism in left ventricular assist device patients: a randomized controlled pilot trial","volume":"10","author":"Andreas","year":"2017","journal-title":"Circ Heart Fail"},{"key":"key\n\t\t\t\t2019041105263149200_b15-0750755","volume-title":"Pradaxa (dabigatran) package insert","year":"2017"},{"key":"key\n\t\t\t\t2019041105263149200_b16-0750755","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/j.jtcvs.2015.10.059","article-title":"Anticoagulation with apixaban in a patient with a left ventricular assist device and gastrointestinal bleeding: a viable alternative to warfarin?","volume":"151","author":"Pollari","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key\n\t\t\t\t2019041105263149200_b17-0750755","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.4022\/jafib.1634","article-title":"Reversal agents in the era of NOACs","volume":"10","author":"Abed","year":"2017","journal-title":"J Atr Fibrillation"},{"key":"key\n\t\t\t\t2019041105263149200_b18-0750755","first-page":"15","article-title":"Increased risk of bleeding in left ventricular assist device patients treated with enoxaparin as bridge to therapeutic INR","author":"Bhatia","year":"2017","journal-title":"ASAIO J"},{"key":"key\n\t\t\t\t2019041105263149200_b19-0750755","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.healun.2015.01.981","article-title":"Bridging with half-therapeutic dose enoxaparin in outpatients with left ventricular assist devices and sub-therapeutic International Normalized Ratios","volume":"34","author":"Borden","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"key\n\t\t\t\t2019041105263149200_b20-0750755","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1345\/aph.1P459","article-title":"Pharmacotherapy for mechanical circulatory support: a comprehensive review","volume":"45","author":"Ensor","year":"2011","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t2019041105263149200_b21-0750755","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.healun.2009.11.604","article-title":"Ideal methodology to assess systemic blood pressure in patients with continuous-flow left ventricular assist devices","volume":"29","author":"Bennett","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"key\n\t\t\t\t2019041105263149200_b22-0750755","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.ajem.2016.04.033","article-title":"The emergency management of ventricular assist devices","volume":"34","author":"Robertson","year":"2016","journal-title":"Am J Emerg Med"},{"key":"key\n\t\t\t\t2019041105263149200_b23-0750755","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/MAJ.0000000000000219","article-title":"Is a palpable pulse always restored during cardiopulmonary resuscitation in a patient with a left ventricular assist device?","volume":"347","author":"Haglund","year":"2014","journal-title":"Am J Med Sci"},{"key":"key\n\t\t\t\t2019041105263149200_b24-0750755","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1177\/2048872615574107","article-title":"Advanced cardiovascular life support algorithm for the management of the hospitalized unresponsive patient on continuous flow left ventricular assist device support outside the intensive care unit","volume":"5","author":"Yuzefpolskaya","year":"2016","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"key\n\t\t\t\t2019041105263149200_b25-0750755","volume-title":"Heart-Ware instructions for use","author":"HeartWare Corporation"},{"key":"key\n\t\t\t\t2019041105263149200_b26-0750755","volume-title":"Resource library (USA): HeartMate II LVAD","author":"Thoratec Corporation"},{"key":"key\n\t\t\t\t2019041105263149200_b27-0750755","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.resuscitation.2014.01.003","article-title":"Chest compressions may be safe in arresting patients with left ventricular assist devices (LVADs)","volume":"85","author":"Shinar","year":"2014","journal-title":"Resuscitation"},{"key":"key\n\t\t\t\t2019041105263149200_b28-0750755","first-page":"2129","article-title":"Anticoagulation management in mechanical circulatory support","volume":"7","author":"Adatya","year":"2015","journal-title":"J Thorac Dis"},{"key":"key\n\t\t\t\t2019041105263149200_b29-0750755","doi-asserted-by":"crossref","first-page":"141","DOI":"10.12659\/MSMBR.894840","article-title":"Continuous-flow left ventricular assist device thrombosis: a danger foreseen is a danger avoided","volume":"21","author":"Fatullayev","year":"2015","journal-title":"Med Sci Monit Basic Res"},{"key":"key\n\t\t\t\t2019041105263149200_b30-0750755","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2146\/ajhp140538","article-title":"Medication management for left ventricular assist device thrombosis","volume":"72","author":"Hohner","year":"2015","journal-title":"Am J Health-Syst Pharm"},{"key":"key\n\t\t\t\t2019041105263149200_b31-0750755","first-page":"2158","article-title":"Dealing with surgical left ventricular assist device complications","volume":"7","author":"Kilic","year":"2015","journal-title":"J Thorac Dis"},{"key":"key\n\t\t\t\t2019041105263149200_b32-0750755","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/MAT.0000000000000449","article-title":"Time in therapeutic range for left ventricular assist device patients anticoagulated with warfarin: a correlation to clinical outcomes","volume":"63","author":"Halder","year":"2017","journal-title":"ASAIO J"},{"key":"key\n\t\t\t\t2019041105263149200_b33-0750755","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MAT.0000000000000047","article-title":"Pharmacist-managed International Normalized Ratio patient self-testing is associated with increased time in therapeutic range in patients with left ventricular assist devices at an academic medical center","volume":"60","author":"Bishop","year":"2014","journal-title":"ASAIO J"},{"key":"key\n\t\t\t\t2019041105263149200_b34-0750755","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/MAT.0000000000000390","article-title":"Effect of CYP2C9 and VKORC1 gene variants on warfarin response in patients with continuous-flow left ventricular assist devices","volume":"62","author":"Topkara","year":"2016","journal-title":"ASAIO J"},{"key":"key\n\t\t\t\t2019041105263149200_b35-0750755","article-title":"INTERMACS adverse event definitions: adult and pediatric patients","author":"Interagency Registry for Mechanically Assisted Circulatory Support"},{"key":"key\n\t\t\t\t2019041105263149200_b36-0750755","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cardfail.2013.12.011","article-title":"Thrombolytic therapy for thrombosis of continuous flow ventricular assist devices","volume":"20","author":"Schlendorf","year":"2014","journal-title":"J Card Fail"},{"key":"key\n\t\t\t\t2019041105263149200_b37-0750755","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.athoracsur.2014.02.041","article-title":"Hemolysis, pump thrombus, and neurologic events in continuous- flow left ventricular assist device recipients","volume":"97","author":"Whitson","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"key\n\t\t\t\t2019041105263149200_b38-0750755","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/MAT.0000000000000012","article-title":"The role of medical management for acute intravascular hemolysis in patients supported on axial flow LVAD","volume":"60","author":"Hasin","year":"2014","journal-title":"ASAIO J"},{"key":"key\n\t\t\t\t2019041105263149200_b39-0750755","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40256-014-0102-3","article-title":"Management of pump thrombosis in patients with left ventricular assist devices","volume":"15","author":"Stulak","year":"2015","journal-title":"Am J Cardiovasc Drugs"},{"key":"key\n\t\t\t\t2019041105263149200_b40-0750755","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.healun.2013.05.002","article-title":"Algorithm for the diagnosis and management of suspected pump thrombus","volume":"32","author":"Goldstein","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"key\n\t\t\t\t2019041105263149200_b41-0750755","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/1076029616672583","article-title":"Direct thrombin inhibitor for LVAD thrombosis: a closer look","volume":"23","author":"Rimsans","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"key":"key\n\t\t\t\t2019041105263149200_b42-0750755","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/icvts\/ivw063","article-title":"Conservative approaches for Heart-Ware ventricular assist device pump thrombosis may improve the outcome compared with immediate surgical approaches","volume":"23","author":"Saeed","year":"2016","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"key\n\t\t\t\t2019041105263149200_b43-0750755","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4103\/0971-9784.173047","article-title":"Intravenous thrombolytic therapy for patients with ventricular assist device thrombosis: an attempt to avoid reoperation","volume":"19","author":"Webber","year":"2016","journal-title":"Ann Cardiac Anaesth"},{"key":"key\n\t\t\t\t2019041105263149200_b44-0750755","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.transproceed.2016.04.025","article-title":"Thrombosis in continuous flow left ventricular assist devices: our clinical experience with medical and surgical management","volume":"48","author":"K\u00f6ksel","year":"2016","journal-title":"Transplant Proc"},{"key":"key\n\t\t\t\t2019041105263149200_b45-0750755","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jchf.2014.11.009","article-title":"Anti-factor Xa and activated partial thromboplastin time measurements for heparin monitoring in mechanical circulatory support","volume":"3","author":"Adatya","year":"2015","journal-title":"JACC Heart Fail"},{"key":"key\n\t\t\t\t2019041105263149200_b46-0750755","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/MAT.0000000000000074","article-title":"Stroke while on long-term left ventricular assist device support: incidence, outcome, and predictors","volume":"60","author":"Morgan","year":"2014","journal-title":"ASAIO J"},{"key":"key\n\t\t\t\t2019041105263149200_b47-0750755","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jchf.2015.05.011","article-title":"The HVAD left ventricular assist device: risk factors for neurological events and risk mitigation strategies","volume":"3","author":"Teuteberg","year":"2015","journal-title":"JACC Heart Fail"},{"key":"key\n\t\t\t\t2019041105263149200_b48-0750755","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.healun.2016.03.014","article-title":"Outcomes after stroke complicating left ventricular assist device","volume":"35","author":"Willey","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"key\n\t\t\t\t2019041105263149200_b49-0750755","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1161\/STROKEAHA.116.014049","article-title":"Stroke risk and mortality in patients with ventricular assist devices","volume":"47","author":"Parikh","year":"2016","journal-title":"Stroke"},{"key":"key\n\t\t\t\t2019041105263149200_b50-0750755","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.athoracsur.2015.02.094","article-title":"Stroke after left ventricular assist device implantation: outcomes in the continuous-flow era","volume":"100","author":"Harvey","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"key\n\t\t\t\t2019041105263149200_b51-0750755","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11906-015-0618-1","article-title":"Hypertension and stroke in patients with left ventricular assist devices","volume":"18","author":"Willey","year":"2016","journal-title":"Curr Hypertens Rep"},{"key":"key\n\t\t\t\t2019041105263149200_b52-0750755","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00394-015-0847-8","article-title":"Vitamin D metabolites and fibroblast growth factor-23 in patients with left ventricular assist device implants: association with stroke and mortality risk","volume":"55","author":"Zittermann","year":"2016","journal-title":"Eur J Nutr"},{"key":"key\n\t\t\t\t2019041105263149200_b53-0750755","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/MAT.0000000000000404","article-title":"Anticoagulation reversal strategies for left ventricular assist device patients presenting with acute intracranial hemorrhage","volume":"62","author":"Wong","year":"2016","journal-title":"ASAIO J"},{"key":"key\n\t\t\t\t2019041105263149200_b54-0750755","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3171\/2013.1.JNS121849","article-title":"Management of intracranial hemorrhage in patients with left ventricular assist devices","volume":"118","author":"Wilson","year":"2013","journal-title":"J Neurosurg"},{"key":"key\n\t\t\t\t2019041105263149200_b55-0750755","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"key":"key\n\t\t\t\t2019041105263149200_b56-0750755","doi-asserted-by":"crossref","first-page":"24","DOI":"10.14797\/mdcj-11-1-24","article-title":"Gastrointestinal bleeding after continuous-flow left ventricular device implantation: review of pathophysiology and management","volume":"11","author":"Guha","year":"2015","journal-title":"Methodist DeBakey Cardiovasc J"},{"key":"key\n\t\t\t\t2019041105263149200_b57-0750755","first-page":"475","article-title":"Gastrointestinal bleed after left ventricular assist device implantation: incidence, management, and prevention","volume":"3","author":"Harvey","year":"2014","journal-title":"Ann Cardiothorac Surg"},{"key":"key\n\t\t\t\t2019041105263149200_b58-0750755","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.cgh.2014.01.027","article-title":"Significantly higher rates of gastrointestinal bleeding and thromboembolic events with left ventricular assist devices","volume":"12","author":"Shrode","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t2019041105263149200_b59-0750755","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/CIRCHEARTFAILURE.111.962613","article-title":"Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices","volume":"4","author":"Suarez","year":"2011","journal-title":"Circ Heart Fail"},{"key":"key\n\t\t\t\t2019041105263149200_b60-0750755","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ejcts.2007.12.047","article-title":"Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease","volume":"33","author":"Geisen","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"key\n\t\t\t\t2019041105263149200_b61-0750755","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/CIRCHEARTFAILURE.109.877597","article-title":"Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device","volume":"3","author":"Meyer","year":"2010","journal-title":"Circ Heart Fail"},{"key":"key\n\t\t\t\t2019041105263149200_b62-0750755","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jchf.2013.10.008","article-title":"Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device","volume":"2","author":"Meyer","year":"2014","journal-title":"JACC Heart Fail"},{"key":"key\n\t\t\t\t2019041105263149200_b63-0750755","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/clc.22096","article-title":"Left ventricular assist devices and gastrointestinal bleeding: a narrative review of case reports and case series","volume":"36","author":"Islam","year":"2013","journal-title":"Clin Cardiol"},{"key":"key\n\t\t\t\t2019041105263149200_b64-0750755","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s10620-015-3538-7","article-title":"Characteristics of gastrointestinal bleeding after placement of continuous-flow left ventricular assist device: a case series","volume":"60","author":"Marsano","year":"2015","journal-title":"Dig Dis Sci"},{"key":"key\n\t\t\t\t2019041105263149200_b65-0750755","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1510\/icvts.2010.240747","article-title":"Discontinuation of anti-thrombotic therapy for a year or more in patients with continuous-flow left ventricular assist devices","volume":"11","author":"Pereira","year":"2010","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"key\n\t\t\t\t2019041105263149200_b66-0750755","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.healun.2015.06.018","article-title":"Safety of reduced anti-thrombotic strategies in HeartMate II patients: a one-year analysis of the US-TRACE Study","volume":"34","author":"Katz","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"key\n\t\t\t\t2019041105263149200_b67-0750755","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/MAT.0000000000000433","article-title":"Inhaled desmopressin for refractory gastrointestinal bleeding in a patient with a HeartMate II left ventricular assist device","volume":"63","author":"Hollis","year":"2017","journal-title":"ASAIO J"},{"key":"key\n\t\t\t\t2019041105263149200_b68-0750755","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/MAT.0000000000000087","article-title":"Treatment of left ventricular assist device-associated arteriovenous malformations with thalidomide","volume":"60","author":"Ray","year":"2014","journal-title":"ASAIO J"},{"key":"key\n\t\t\t\t2019041105263149200_b69-0750755","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jchf.2015.06.016","article-title":"Inhibition of ADAMTS-13 by doxycycline reduces von Willebrand factor degradation during supraphysiological shear stress: therapeutic implications for left ventricular assist device-associated bleeding","volume":"3","author":"Bartoli","year":"2015","journal-title":"JACC Heart Fail"},{"key":"key\n\t\t\t\t2019041105263149200_b70-0750755","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/cid\/cit536","article-title":"Clinical manifestations and management of left ventricular assist device-associated infections","volume":"57","author":"Nienaber","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019041105263149200_b71-0750755","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.transproceed.2013.11.106","article-title":"Importance of early appropriate intervention including antibiotics and wound care for device-related infection in patients with left ventricular assist device","volume":"46","author":"Hieda","year":"2014","journal-title":"Transplant Proc"},{"key":"key\n\t\t\t\t2019041105263149200_b72-0750755","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1086\/509640","article-title":"Candidemia in patients with ventricular assist devices","volume":"44","author":"Shoham","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019041105263149200_b73-0750755","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.healun.2014.05.011","article-title":"Evolution and impact of drive-line infection in a large cohort of continuous-flow ventricular assist device recipients","volume":"33","author":"Koval","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"key\n\t\t\t\t2019041105263149200_b74-0750755","first-page":"2151","article-title":"Left ventricular assist device driveline infections: recent advances and future goals","volume":"7","author":"Leuck","year":"2015","journal-title":"J Thorac Dis"},{"key":"key\n\t\t\t\t2019041105263149200_b75-0750755","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1161\/CIRCULATIONAHA.109.192665","article-title":"Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association","volume":"121","author":"Baddour","year":"2010","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041105263149200_b76-0750755","doi-asserted-by":"crossref","first-page":"270","DOI":"10.5301\/ijao.5000285","article-title":"Dosing of vancomycin in patients with continuous-flow left ventricular assist devices: a clinical pharmacokinetic analysis","volume":"37","author":"Jennings","year":"2014","journal-title":"Int J Artif Organs"},{"key":"key\n\t\t\t\t2019041105263149200_b77-0750755","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ccl.2011.08.004","article-title":"Left ventricular assist device driveline infections","volume":"29","author":"Pereda","year":"2011","journal-title":"Cardiol Clin"},{"key":"key\n\t\t\t\t2019041105263149200_b78-0750755","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/aor.12254","article-title":"Clinical outcomes associated with chronic antimicrobial suppression therapy in patients with continuous-flow left ventricular assist devices","volume":"38","author":"Jennings","year":"2014","journal-title":"Artif Organs"},{"key":"key\n\t\t\t\t2019041105263149200_b79-0750755","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ahj.2012.06.018","article-title":"Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation","volume":"164","author":"Raasch","year":"2012","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t2019041105263149200_b80-0750755","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/HCO.0b013e32834d84fd","article-title":"Arrhythmias in patients with ventricular assist devices","volume":"27","author":"Boyle","year":"2012","journal-title":"Curr Opin Cardiol"},{"key":"key\n\t\t\t\t2019041105263149200_b81-0750755","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijcard.2016.07.257","article-title":"The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices\u2014a meta-analysis","volume":"222","author":"Agrawal","year":"2016","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t2019041105263149200_b82-0750755","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/MAT.0000000000000349","article-title":"Arrhythmias in patients with cardiac implantable electrical devices after implantation of a left ventricular assist device","volume":"62","author":"Rosenbaum","year":"2016","journal-title":"ASAIO J"},{"key":"key\n\t\t\t\t2019041105263149200_b83-0750755","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/CIRCHEARTFAILURE.111.964031","article-title":"Adipose tissue inflammation and adiponectin resistance in patients with advanced heart failure: correction after ventricular assist device implantation","volume":"5","author":"Khan","year":"2012","journal-title":"Circ Heart Fail"},{"key":"key\n\t\t\t\t2019041105263149200_b84-0750755","doi-asserted-by":"crossref","first-page":"E98","DOI":"10.1532\/HSF98.2013323","article-title":"Neurohormonal regulation and improvement in blood glucose control: reduction of insulin requirement in patients with a nonpulsatile ventricular assist device","volume":"17","author":"Koerner","year":"2014","journal-title":"Heart Surg Forum"},{"key":"key\n\t\t\t\t2019041105263149200_b85-0750755","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/eurjhf\/hfq204","article-title":"Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices","volume":"13","author":"Uriel","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t2019041105263149200_b86-0750755","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/MAT.0000000000000127","article-title":"Improvement in glycemic control after left ventricular assist device implantation in advanced heart failure patients with diabetes mellitus","volume":"60","author":"Choudhary","year":"2014","journal-title":"ASAIO J"},{"key":"key\n\t\t\t\t2019041105263149200_b87-0750755","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/MAT.0000000000000064","article-title":"Improvement in blood glucose control in patients with diabetes after implantation of left ventricular assist devices","volume":"60","author":"Guglin","year":"2014","journal-title":"ASAIO J"},{"key":"key\n\t\t\t\t2019041105263149200_b88-0750755","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/ejhf.166","article-title":"Mechanical circulatory support improves diabetic control in patients with advanced heart failure","volume":"16","author":"Mohamedali","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t2019041105263149200_b89-0750755","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cardfail.2016.02.010","article-title":"Outcomes for patients with diabetes after continuous-flow left ventricular assist device implantation","volume":"22","author":"Vest","year":"2016","journal-title":"J Card Fail"},{"key":"key\n\t\t\t\t2019041105263149200_b90-0750755","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/phar.1853","article-title":"Positive impact of continuous-flow left ventricular assist device implantation on glycemic control in patients with type 2 diabetes mellitus and advanced chronic systolic heart failure","volume":"36","author":"Yen","year":"2016","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t2019041105263149200_b91-0750755","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/ejcts\/ezv221","article-title":"Does postoperative blood pressure influence development of aortic regurgitation following continuous-flow left ventricular assist device implantation?","volume":"49","author":"Patil","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"key\n\t\t\t\t2019041105263149200_b92-0750755","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.jacc.2009.06.035","article-title":"Ventricular assist devices: the challenges of outpatient management","volume":"54","author":"Wilson","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041105263149200_b93-0750755","doi-asserted-by":"crossref","first-page":"33","DOI":"10.14797\/mdcj-11-1-33","article-title":"Continuous flow left ventricular assist devices: shared care goals of monitoring and treating patients","volume":"11","author":"Estep","year":"2015","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"key\n\t\t\t\t2019041105263149200_b94-0750755","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.athoracsur.2013.07.069","article-title":"Blood pressure control in continuous flow left ventricular assist devices: efficacy and impact on adverse events","volume":"97","author":"Lampert","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"key\n\t\t\t\t2019041105263149200_b95-0750755","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.cardfail.2016.02.004","article-title":"Use of heart failure medical therapies among patients with left ventricular assist devices: insights from INTERMACS","volume":"22","author":"Khazanie","year":"2016","journal-title":"J Card Fail"},{"key":"key\n\t\t\t\t2019041105263149200_b96-0750755","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ahj.2016.06.011","article-title":"Heart failure medications prescribed at discharge for patients with left ventricular assist devices","volume":"179","author":"Shreibati","year":"2016","journal-title":"Am Heart J"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/75\/11\/755\/28346204\/ajhp0755.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T05:03:50Z","timestamp":1661317430000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/75\/11\/755\/5102012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":96,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp170317","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,6,1]]},"published":{"date-parts":[[2018,6,1]]}}}